UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
 
For the month of May 2023
 
COMMISSION FILE NUMBER 001-38455
 
MorphoSys AG
 
Semmelweisstrasse 7
82152 Planegg
Germany
(Address of principal executive offices)
 
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F: Form 20-F x Form 40-F ¨
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨






On May 05, 2023, MorphoSys AG (the “Company”) published a notification of managers transactions from Charlotte Lohmann.



Exhibits

99.1    Notification of managers`transactions according to article 19 MAR




SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

    MORPHOSYS AG (Registrant)

Date: May 5, 2023    By:    /s/ i.A. Kristina Grötsch
        Name: Kristina Grötsch
        Title:    Senior Specialist Investor Relation
    

    By:    /s/ i.A. Isabelle Degbegni
        Name: Isabelle Degbegni
        Title:    Director Investor Relations     



Notification of managers`transactions according to article 19 MAR

1
Details of the person discharging managerial responsibilities/person closely associated
a)NameCharlotte Lohmann
2
Reason for the notification
a)Position/statusMember of the managing body
b)Initial notification/AmendmentInitial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)NameMorphoSys AG
b)LEI529900493806K77LRE72
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument. type of instrument
Identification code
Shares of MorphoSys AG, ISIN DE0006632003
b)Nature of the transactionAllocation of 157 shares as part of her remuneration as member of the Managing Board (Performance Share Plan 2019) (issuer's own shares)
c)Price(s) and volume(s)Price
Volume

Not numerable
Not numerable
d)Aggregated information
Aggregated volume


Price


Not numerable

Not numerable
e)Date of the transaction2023-05-04; UTC+2
f)Place of the transactionOutside a trading venue